Recent literature has shown that AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors lacking the GluR2 subunit (thus calcium permeable) are widely expressed in the CNS, especially in interneurons and glia, where they contribute to synaptic transmission and plasticity. Studies have also indicated that calcium permeable AMPARs (CP-AMPARs) are expressed and participate in synaptic regulation in principal neurons, including hippocampal pyramidal neurons. Furthermore, CP-AMPARs and their resultant calcium influx are implicated in various pathophysiological conditions such as ischemia and seizures. However, the synaptic events activated by calcium influx through CP-AMPARs remain unknown. I took advantage of genetically altered mice without (GluR2-/-) or with reduced GluR2 (GluR2+/-), thus allowing the expression and detailed analysis of synaptic CP-AMPARs in hippocampal pyramidal neurons. Utilizing electrophysiological techniques, I demonstrated that these receptors were capable of inducing numerous forms of long-term potentiation (referred to as CP-AMPAR-dependent LTP) through a number of different induction protocols, including high-frequency stimulation (HFS) and theta-burst stimulation (TBS). This included a previously undemonstrated form of protein-synthesis dependent late-LTP (L-LTP) at CA1 synapses that is NMDA-receptor (NMDAR) independent. This form of plasticity was completely blocked by the selective CP-AMPAR inhibitor IEM-1460. Surprisingly, calcium/calmodulin-dependent kinase II (CaMKII), the key protein kinase that is indispensable for NMDAR-dependent LTP at CA1 synapses appeared to be not required for the induction of CP-AMPAR-dependent LTP due to the lack of effect of two separate pharmacological inhibitors (KN-62 and staurosporine) on this form of potentiation. Both KN-62 and staurosporine strongly inhibited NMDAR dependent LTP in control studies. In contrast, inhibitors for the extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) cascade (PD98059 and U0126) significantly attenuated this CP-AMPAR-dependent LTP. Additional studies with knockout mice revealed that the ERK/MAPK signalling cascade is likely acting through p-21 activated kinase 1 (or PAK1, a Rho-GTPase associated kinase) dependent mechanisms. These results suggest that distinct synaptic signalling underlies GluR2-lacking CP-AMPAR-dependent LTP, and reinforces the recent notions that CP-AMPARs are important facilitators of synaptic plasticity in the brain.

Recent literature has shown that AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptors lacking the GluR2 subunit (thus calcium permeable) are widely expressed in the CNS, especially in interneurons and glia, where they contribute to synaptic transmission and plasticity. Studies have also indicated that calcium permeable AMPARs (CP-AMPARs) are expressed and participate in synaptic regulation in principal neurons, including hippocampal pyramidal neurons. Furthermore, CP-AMPARs and their resultant calcium influx are implicated in various pathophysiological conditions such as ischemia and seizures. However, the synaptic events activated by calcium influx through CP-AMPARs remain unknown. I took advantage of genetically altered mice without (GluR2-/-) or with reduced GluR2 (GluR2+/-), thus allowing the expression and detailed analysis of synaptic CP-AMPARs in hippocampal pyramidal neurons. Utilizing electrophysiological techniques, I demonstrated that these receptors were capable of inducing numerous forms of long-term potentiation (referred to as CP-AMPAR-dependent LTP) through a number of different induction protocols, including high-frequency stimulation (HFS) and theta-burst stimulation (TBS). This included a previously undemonstrated form of protein-synthesis dependent late-LTP (L-LTP) at CA1 synapses that is NMDA-receptor (NMDAR) independent. This form of plasticity was completely blocked by the selective CP-AMPAR inhibitor IEM-1460. Surprisingly, calcium/calmodulin-dependent kinase II (CaMKII), the key protein kinase that is indispensable for NMDAR-dependent LTP at CA1 synapses appeared to be not required for the induction of CP-AMPAR-dependent LTP due to the lack of effect of two separate pharmacological inhibitors (KN-62 and staurosporine) on this form of potentiation. Both KN-62 and staurosporine strongly inhibited NMDAR dependent LTP in control studies. In contrast, inhibitors for the extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) cascade (PD98059 and U0126) significantly attenuated this CP-AMPAR-dependent LTP. Additional studies with knockout mice revealed that the ERK/MAPK signalling cascade is likely acting through p-21 activated kinase 1 (or PAK1, a Rho-GTPase associated kinase) dependent mechanisms. These results suggest that distinct synaptic signalling underlies GluR2-lacking CP-AMPAR-dependent LTP, and reinforces the recent notions that CP-AMPARs are important facilitators of synaptic plasticity in the brain.

Le travail retranscrit dans cette thèse regroupe l'étude de différents processus biologiques impliqués dans la synthèse protéique bactérienne. Dans un premier chapitre, les origines de la synthèse protéique au temps du monde ARN sont traitées en guise d'introduction. Ce travail théorique se poursuit par la présentation d'une structure à haute résolution du facteur d'élongation G (EF-G) en complexe avec le ribosome par cryo-microscopie électronique à transmission (cryo-MET). Grâce aux avancées techniques de la cryo-MET, nous avons observé pour la première fois EF-G lié au ribosome en l'absence de tout inhibiteur. Cet état particulièr d'EF-G permet de visualiser une flexibilité de son doamine III. Cette étude permet aussi de rationaliser le fonctionnement de l'antibiotique acide fusidique. Nous nous sommes ensuite intéressés aux voies de sauvetage de la synthèse protéique et plus particulièrement de la trans-traduction. Ce mécanisme fascinant permet le recyclage des ribosomes bloqués sur un ARN messager défectueux. Cette voie de sauvetage est généralement vitale ou alors indispensable pour la virulence bactérienne. Nous avons réalisé une étude structurale préliminaire de la dégradation de l'ARNm défectueux durant ce processus. Après une revue traitant du sujet, nous présentons une étude de la trans-traduction comme cible pour le développement de nouveaux antibiotiques. Pour cela, nous avons mis au point un système rapporteur avec contrôle interne de l'activité trans-traductionnelle bactérienne. Après avoir mis au point ce système et validé son utilisation, nous l'avons exploité en testant des molécules ciblant la trans-traduction. / The current PhD work brings together various studies linked to bacterial protein synthesis. The first chapter is about the origins of protein synthesis at the time of the RNA world. This theoretical work continues with the presentation of a high-resolution structure of the elongation factor G (EF-G) in complex with the ribosome by cryo-electron transmission microscopy (cryo-TEM). We describe for the first time EF-G bound to the ribosome in the absence of any inhibitor. This particular structure of EF-G displays a yet unseen positioning of its third domain, which becomes very flexible. This study helps to understand the way the antibiotic fusidic acid blocks translation. The work then switches to a study of trans-translation, the main rescuing system of stalled ribosomes in bacteria. Trans-translation is generally vital or at least necessary for bacterial virulence. We conducted a preliminary structural study on the way faulty mRNAs are degraded during this process. This is why we present a study of trans-translation as a target for the development of new antibiotics. For this we developed and validated a reporter system for trans-translation, which is used to screen molecules targeting trans-translation.

Les cardiolipines (CL) sont des phospholipides possédant de nombreux rôles dans la structure et le fonctionnement des mitochondries. Elles sont, par exemple, impliquées dans la stabilisation des complexes des oxydations phosphorylantes, la fusion/fission des membranes mitochondriales, l’import de protéines mitochondriales, la biogénèse des centres fer-soufre (Fe-S), l’apoptose, la protection des mitochondries contre le stress oxydatif…L’ensemble de ces fonctions nécessitent que les chaînes d’acides gras de la CL soient majoritairement insaturées. Le maintien de cette composition en chaînes insaturées requiert une activité acyltransférase portée par la protéine tafazzine, qui est codée par le gène nucléaire TAZ. Des mutations dans ce gène sont la cause du syndrome de Barth (BTHS), qui se caractérise notamment par des myopathies cardiaques et squelettiques, une neutropénie (responsable de nombreuses infections) et des défauts de la chaîne respiratoire. Malgré des progrès considérables dans la compréhension des mécanismes conduisant à la pathogénicité, il n’existe toujours aucune thérapie pour traiter cette maladie. Nous avons donc utilisé la levure Saccharomyces cerevisiae, chez qui la voie de remodelage des CL par la tafazzine est bien conservée, pour modéliser le BTHS et, ainsi non seulement étudier les mécanismes moléculaires sous-jacents de cette maladie, mais aussi identifier différentes voies thérapeutiques potentielles (suppresseurs génétiques et molécules pharmacologiques). Nous avons tout d’abord construit une levure délétée pour le gène orthologue TAZ (TAZ1 chez la levure), la souche Δtaz1. En accord avec des études précédentes, la souche Δtaz1 présente une diminution quantitative de la CL accompagnée d’un changement qualitatif des chaînes d’acides gras1,2 (plus d’acides gras saturés et moins d’insaturés). Nous montrons aussi que cette levure mutante a un défaut de croissance en milieu respiratoire à température élevée (36°C) ainsi que des défauts dans plusieurs composants impliqués dans les oxydations phosphorylantes2. De façon intéressante, alors que le défaut primaire (diminution des CL et changement qualitatif des chaines d’acide gras) est toujours présent, nous montrons que les oxydations phosphorylantes sont restaurées dans la souche Δtaz1 surexprimant Odc1p2, un transporteur mitochondrial d’intermédiaires du cycle de Krebs, ou par plusieurs composés chimiques. Plusieurs de ces drogues sauvant le mutant, dont la cycloheximide, sont des inhibiteurs partiels de la synthèse protéique cytosolique. Cet effet a été confirmé génétiquement par des mutations affectant les ribosomes cytosoliques. L’ensemble des résultats suggère qu’un défaut au niveau des CL provoquerait un stress protéostatique probablement impliqué dans le processus pathologique. / The phospholipid cardiolipin (CL) has many roles in mitochondrial structure and function, ranging from assembly/stability and functioning of the oxidative phosphorylation (OXPHOS) system, fusion and fission of mitochondrial membranes, mitochondrial protein import, iron-sulfur (Fe-S) biogenesis, apoptosis, and protection of mitochondria against oxidative damage. The maintenance of a proper unsaturated acyl chain composition of CL involves the acyltransferase tafazzin in which mutations cause Barth syndrome (BTHS), resulting in cardiac and skeletal myopathy, cyclic neutropenia and respiratory chain defects. Despite considerable progress in the understanding of the underlying pathogenic mechanisms, there are still no effective therapies to treat this disease. We are using the yeast Saccharomyces cerevisiae, in which the tafazzin-based cardiolipin remodeling pathway is conserved, as a model system for the exploration of potential therapeutic pathways against BTHS, by way of genetic suppressors and chemical screening. We first constructed a yeast strain lacking the orthologous taffazin gene (Δtaz1). Consistent with previous studies, our Δtaz1 yeast failed to grow on non-fermentable carbon sources at elevated temperatures (36°C) and exhibited defects in several components of the mitochondrial respiratory system. Interestingly, we found that oxidative phosphorylation was fully restored in Δtaz1 yeast by overexpressing Odc1p [1]-a mitochondrial carrier that transports Krebs cycle intermediates- and by a number of chemical compounds. Some of the rescuing drugs, especially cycloheximide, act by partially inhibiting cytosolic protein synthesis leading to a full recovery of oxidative phosphorylations. Our findings identify potential cellular components and pathways for the pharmacological treatment of BTHS patients.

Au cours du vieillissement, l’organisme subit de nombreuses altérations, dont une perte de masse et de fonction musculaire appelée sarcopénie. Ses causes sont multifactorielles. Elle est partiellement liée à une altération de la stimulation de la synthèse protéique musculaire post-prandiale, et certains facteurs tels que le stress oxydant, l’inflammation et la résistance à l’insuline, responsables de nombreux dysfonctionnements métaboliques, accélèrent ce phénomène. Or, ces dérégulations peuvent être induites par une alimentation trop riche en sucres ajoutés, caractéristique des habitudes alimentaires actuelles et qui pourrait donc accélérer le vieillissement. Pourtant, à ce jour, peu d'études ont étudié les effets combinés du vieillissement et d'un régime riche en sucres ajoutés, et à notre connaissance, aucune ne s’est intéressée à la sarcopénie. Ainsi, notre objectif au cours de cette thèse a été de déterminer si un régime riche en sucres ajoutés était capable d'accélérer la sarcopénie. Il était également intéressant d'étudier les effets combinés du vieillissement et de ce régime sur d'autres tissus qui semblent particulièrement exposés, le foie, et le cerveau. Enfin, nous avons également voulu analyser les effets préventifs d'un mélange de micronutriments à la fois in vivo et in vitro. Pour cela, des rats âgés de 16 mois ont été nourris durant 5 mois avec un régime contrôle ou un régime composé à 62% de saccharose, supplémenté ou non en rutine, vitamine A, vitamine E, vitamine D, zinc, et sélénium. En outre, nous avons également inclut un groupe de témoins adultes (8 mois), nourris avec un régime contrôle. Par ailleurs, les effets anti-inflammatoires des micronutriments ont été testés in vitro.Nous avons pu constater que le régime riche en saccharose a accéléré la perte de masse musculaire liée à l’âge en altérant la synthèse protéique musculaire post prandiale, vraisemblablement via l’altération de la sensibilité à l’insuline plutôt que par une augmentation du stress oxydant et de l'inflammation, qui ont été peu affectés par le régime. Il a également entraîné un gain de masse grasse et une augmentation marquée des triglycérides hépatiques et plasmatiques, qui pourraient en partie s’expliquer par une modification de l’activité des enzymes du métabolisme lipidique dans le foie. Au niveau cérébral, la surconsommation de fructose a entraîné une diminution de la concentration protéique qui ne semble pas due à un défaut de synthèse protéique. La supplémentation en micronutriments n’a que partiellement contrecarré les effets du saccharose puisqu’elle n’a pas eu d’effet sur la masse maigre mais a permis de limiter la prise de masse grasse, notamment en inhibant la lipogenèse hépatique. Elle a également restauré la synthèse protéique diminuée au cours du vieillissement dans le cerveau. In vitro, elle a permis de réduire l'inflammation induite expérimentalement.Ainsi, cette thèse a permis de montrer qu’un régime riche en sucres ajoutés accélère la sarcopénie chez le rat âgé mais entraîne également des altérations au niveau hépatique et cérébral. La prévention par les micronutriments testés reste malgré tout limitée. / With aging, several alterations occur, including a loss of muscle mass and function, called sarcopenia. Many factors are responsible for the development of sarcopenia, but some factors as inflammation, oxidative stress and insulin resistance, which have many deleterious effects during aging, can reduce meal-induced stimulation of muscle protein synthesis which was shown to partly explain age-related muscle mass loss. Those factors can be induced by a diet rich in added sugar, characteristic of current dietary habits. Although this kind of diet could accelerate aging features, little is known about combined effect of aging and high sugar diet, particularly on sarcopenia. Thus, the purpose of this work was to determine whether high chronic intake of added sugars could accelerate sarcopenia. We also interested in the combined effect of added sugars and aging on other exposed tissues: liver and brain. Finally, we assessed the preventive effects of a micronutrient supplementation both in vivo and in vitro.In order to do that, for 5 months, 16 month old rats were starch fed or sucrose fed (62% sucrose), with or without micronutrients supplementation (rutin, vitamin A, vitamin E, vitamin D, selenium and zinc). Additionally, an adult control group of 8 month old rats was included. Besides, anti-inflammatory effects of micronutrients were tested in vitro.We showed that high sucrose diet accelerated age-related muscle mass loss by impairing postprandial protein synthesis, likely through decreased insulin sensitivity since inflammation and oxidative stress were only slightly affected by high sucrose diet. This diet also resulted in fat mass gain and increased plasma and liver triglycerides, by modulating the activity of enzymes involved in liver lipid metabolism. In the brain, high sucrose consumption led to decreased protein concentration independently of protein synthesis alteration. Micronutrients supplementation only partially reversed high sucrose diet effects: it did not act on lean body mass but prevented fat mass gain, by inhibiting hepatic lipogenesis. It also restored brain protein synthesis, which was reduced by aging. In vitro, it reduced experimentally induced inflammation.Thus, this work showed that a high sucrose diet accelerates sarcopenia in old rats but also induces liver and brain alterations. Prevention by micronutrients remained limited.

No description available.

No description available.

The process of translation initiation is the most highly regulated step of protein synthesis. In bacteria, three initiation factors (IF1, IF2 and IF3) play crucial roles during initiation. IF3 acts as an anti-association factor for the two ribosomal subunits. Eubacterial IF3 also permits initiator tRNA (i-tRNA) selection at the P site of the ribosome. Two features of i-tRNA, i. e. the characteristic 3GC base pairs in the anticodon stem and the cognate interaction of the anticodon sequence with the initiation codon of the mRNA contribute to IF3 based selection and/or proofreading. However, the exact mechanism of this discrimination and the contribution of the individual domains towards this process of selection/ proofreading are unclear. Further, there are exceptional instances in the natural world where either the codon-anticodon interaction or the anticodon stem composition deviates from the norm. For instance, in mammalian mitochondria, non-AUG codons such as AUU and AUA are present in the genome although they are notoriously poor initiation codons. In addition, some species of Mycoplasma have i-tRNAs with variations in the typically conserved 3GC base pairs of the anticodon stem. In this study, we have investigated the mechanism of proofreading activity of IF3 of E. coli, mitochondrial and mycoplasmal origins. Part I: Proofreading function of IF3 in E. coli IF3 is composed of N and C terminal domains joined by a flexible linker region. By means of complete and partial IF3 knockouts, we show that the C-terminal domain (CTD) is essential for the survival of E. coli while the N-terminal (NTD) is required for cellular fitness. Using reporter assays, we have established the role of the NTD in proofreading, while polysome profile analyses reaffirm that the CTD alone can bind to the 30S and carry out ribosome anti-association. Therefore, we show that the CTD is the ribosome binding and anti-association domain, while the NTD is the major proofreading domain. Unpublished cryoEM structures from Prof. Ramakrishnan’s lab indicate that the NTD of IF3 pushes the i-tRNA at its elbow and helps in P site accommodation of the i-tRNA. We propose that when the codon-anticodon interaction is non-cognate or if the 3GC base pairs of the anticodon stem are not intact, then the dynamic action of the NTD destabilises the tRNA at the P site and leads to its rejection. Part II: Proofreading function of mitochondrial IF3 (IF3mt) Of the 13 protein-coding genes in mammalian mitochondria, 3 utilise the non-canonical AUA codon and one utilises the non-canonical start codon AUU. Since IF3mt does not possess many of the generally conserved residues implicated in proofreading, we decided to characterise the proofreading function of IF3mt and its role in initiation with non-canonical start codons. Structurally, IF3mt is similar to EcoIF3 with its N and C terminal domains joined by a linker region. However, IF3mt additionally possesses N- and C-terminal extensions which are generally disordered in structure. In vivo studies of mitochondrial translation factors have been mired by the lack of methodologies to manipulate mitochondria. We have developed an E. coli strain to study the proofreading functions of mitochondrial IF3 (IF3mt) with the help of reporter genes. Consistent with its function in mitochondria, IF3mt allowed promiscuous initiation from non-AUG codons. However, IF3mt avoided initiation with i-tRNAs lacking evolutionarily conserved 3GC pairs in anticodon stems. Interestingly, expression of IF3mt N-terminal domain or IF3mt devoid of its typical N-, and C-terminal extensions significantly improved its proofreading activity. Our immunoblot assays from polysome profile fractions indicate that the IF3mt derivative lacking extensions is capable of superior 30S ribosome binding. The two derivatives of IF3mt missing the Next (IF3mtΔNext) or both the Next and Cext (IF3mtΔNextCext) display an affinity for the 50S ribosome. We propose that the extensions of IF3mt may have evolved to reduce the affinity of IF3mt to the ribosome and thereby permit initiation with non-canonical start codons like AUU and AUA. Our studies suggest that E. coli provides an excellent heterologous model to study distinctive features of mitochondrial factors. Part III: Fidelity of translation initiation in mycoplasma One of the many singular features of mycoplasma is the presence of many anticodon stem variants of the i-tRNA across different species. In general, i-tRNAs are characterized by the presence of the typical feature of the conserved 3 consecutive GC base pairs (GC/GC/GC) in the anticodon stem. However, many mycoplasmal species have i-tRNAs with AU/GC/GC, GC/GC/GU or AU/GC/GU sequences. Interestingly, the mycoplasmal species which harbour the AU/GC/GU i-tRNA are also human pathogens. Therefore, we decided to investigate whether these organisms possess any unique features to accommodate the i-tRNA variants, by investigating the usage of Shine Dalgarno sequences and by carrying out multiple sequence alignments of genes encoding initiation factors, ribosomal proteins S9 and S13 and 16S rRNA. Since IF3 plays a crucial role in i-tRNA selection, we carried out computational analysis of mycoplasmal IF3 sequences, which revealed many interesting features. Most striking amongst them was the variation of the highly conserved R at position 131 in some species. Interestingly, these were the very mycoplasmal species which possessed the anticodon stem variant AU/GC/GU, suggesting a strong correlation between these two features. It is known that the R131P mutation of EcoIF3 is characterised by an enormous loss of proofreading activity. It seemed unusual that such compromised proofreading would be tolerated in the cell, so we decided to investigate other components of the translational machinery as well. The C-terminal SKR tail of the ribosomal protein S9, which contacts the P-site tRNA, is highly conserved across bacteria. Analysis of the C-terminal sequences of S9 proteins in various mycoplasmal species revealed a surprising variation- the presence of a TKR tail in strains with the AU/GC/GU tRNA. In this study we have investigated the co-occurrence of S9 and IF3 variations in i-tRNA selection in E. coli. We see that the R131P polymorphism of IF3 leads to a tremendous loss of proofreading, but this loss is significantly tempered by the presence of the S9 TKR variation. Our bioinformatics studies revealed that the mycoplasmal species which are sustained on AU/GC/GU i-tRNAs also tend to use a higher percentage of non-AUG codons. By means of our reporter assays in E. coli, we have shown once again that the R131P polymorphism of IF3 leads to a tremendous increase in initiation with the non-canonical start codon AUA, but this increase is significantly tempered by the presence of the S9 TKR variation.

No description available.

Si les différentes composantes du syndrome métabolique (SM) sont susceptibles d’affecter le métabolisme protéique et des acides aminés (AA), les données disponibles sont peu nombreuses et souvent contradictoires, du fait de l’hétérogénéité de présentation de ce syndrome et des limites des approches classiques d’investigation du métabolisme azoté. Ce travail de thèse met à profit une nouvelle approche isotopomique, s’appuyant sur la mesure de l’abondance naturelle des isotopes stables de l’azote (δ15N) et du carbone (δ13C) dans les protéines et AA tissulaires pour identifier les altérations du métabolisme protéique survenant lors de l’induction nutritionnelle d’un SM chez le rat. Nos résultats permettent dans un premier temps de valider expérimentalement les prédictions d’un modèle multi-compartimental développé dans le laboratoire et montrant que les δ15N reflètent l’orientation différentielle des AA entre les voies anaboliques (protéosynthèse) et cataboliques (oxydation). Nous avons également montré que sous certaines conditions, les δ13C permettent d’estimer la part des carbones des AA et protéines tissulaires provenant respectivement des protéines, glucides et lipides alimentaires, renseignant ainsi sur la flexibilité métabolique des individus. Les mesures de δ15N et δ13C dans les protéines et AA, seules ou combinées à la mesure des taux de synthèse protéique après administration d’eau deutérée, nous ont ensuite permis de mettre en évidence les modifications du métabolisme protéique et des AA survenant lors de l’exposition périnatale et post-sevrage à un régime gras et sucré, ainsi que celles associées à des différences de sensibilité individuelles à l’induction d’un syndrome métabolique par ce même type de régime. Ces altérations sont tissu-spécifiques et diffèrent selon qu’elles proviennent uniquement de différences de sensibilité individuelle au régime ou qu’elles sont également attribuables à des différences d’équilibre glucido-lipidique dans l’alimentation. L’ensemble de nos résultats montrent que l’apparition d’un SM est associée à des réorientations du métabolisme des AA entre les voies anaboliques et d’oxydation, affectant de façon différente le foie, le muscle, l’intestin et le tissu adipeux, et à une altération de la flexibilité métabolique dans le muscle. Ces travaux ouvrent la voie à des études chez l’Homme, s’appuyant sur les mesures de δ15N et δ13C dans des pools accessibles. / Although the different components of the metabolic syndrome (MS) are likely to affect protein and amino acid (AA) metabolism, the available data are few and often contradictory, due to the heterogeneity of presentation of this syndrome and the limitations of classical approaches to investigate nitrogen metabolism. The present thesis work uses a novel isotopomic approach, based on the measurement of the natural abundance of stable isotopes of nitrogen (δ15N) and carbon (δ13C) in tissue proteins and AA to identify alterations in protein metabolism occurring during the nutritional induction of MS in rats. Our results allow to validate experimentally the predictions of a multi-compartimental model developed in the laboratory and showing that the δ15N reflects the differential orientation of AA between anabolic (proteosynthesis) and catabolic (oxidation) pathways. We have also shown that under certain conditions, the δ13C can allow to estimate the proportion of carbons in AA and tissue proteins issuing from dietary proteins, carbohydrates and lipids respectively, thus providing information on the metabolic flexibility of individuals. The measurements of δ15N and δ13C in proteins and AA, alone or combined with the measurement of protein synthesis rates after administration of deuterated water, then allowed us to highlight the changes in protein and AA metabolism occurring during perinatal and post-weaning exposure to a high-fat high-sugar diet, as well as those associated with individual differences in sensitivity to the induction of a MS by the same kind of diet. These alterations are tissuespecific and differ according to whether they result solely from differences in individual sensitivity to diet or whether they are also attributable to differences in the carbohydrate/lipid balance of the diet. Altogether, our results show that the development of MS is associated with changes in AA metabolic partitioning between the anabolic and oxidative pathways, differently affecting the liver, muscle, intestine and adipose tissue, and with an altered metabolic flexibility in muscle. This work opens the way to human studies, based on the measurements of δ15N and δ 13C in accessible pools.